TY  - JOUR
AU  - Carmona, I
AU  - Cordero, P
AU  - Ampuero, J
AU  - Rojas, A
AU  - Romero-Gómez, M
PY  - 2016
DO  - 10.1016/j.cmi.2016.09.017
UR  - http://hdl.handle.net/10668/10478
T2  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
AB  - Fibrosis progression is common in hepatitis C. Both host and viral factors influence its natural history. Liver fibrosis is a key predictive factor for advanced disease including endpoints such as liver failure, cirrhosis and hepatocellular carcinoma...
LA  - en
KW  - Direct-acting antiviral
KW  - Hepatitis C
KW  - Liver biopsy
KW  - Non-invasive markers
KW  - Pegylated interferon
KW  - Antiviral Agents
KW  - Clinical Trials as Topic
KW  - Disease Management
KW  - Disease Progression
KW  - Hepatitis C, Chronic
KW  - Humans
KW  - Liver Cirrhosis
KW  - Sustained Virologic Response
TI  - Role of assessing liver fibrosis in management of chronic hepatitis C virus infection.
TY  - research article
VL  - 22
ER  -